How Israel’s Wartime Know-How is Quietly Shaping the Next Decade of Global Tech
Dave Gordon
War has long been Israel’s harshest teacher, forcing engineers, doctors, and scientists to improvise under pressure and turn urgent problems into practical solutions.
Today, however, the country’s most important innovations are moving beyond helmets and drones onto cancer wards, university labs, and lunar missions.
A grandmother in Tel Aviv whose multiple myeloma responds to a new homegrown therapy, a finance worker in New York whose inbox quietly filters out a sophisticated phishing scam, and an engineer watching an early test of a laser interceptor are all touched by the same mindset.
From artificial intelligence that quietly guards your email to homegrown therapies that re‑engineer immune cells, Israeli ingenuity is now shaping how the world will communicate, heal, and explore in the next decade.
Globalization of New Interdisciplinary Tools from Israel
This is the story beyond the battlefield: how Israel’s ecosystem of universities, startups, and global tech partners is taking wartime know‑how and transforming it into civilian tools for medicine, business, and space – and how those ideas can be adopted globally despite political challenges.
Professor Zeev Zalevsky is an Israeli physicist and engineer. He is Vice President for Academia–Industry Relations and Innovation at Bar‑Ilan University and is an internationally recognized expert in nanophotonics and biomedical optics. Nanophotonics or nano-optics is the study of the behavior of light on the nanometer scale, and of the interaction of nanometer-scale objects with light. It is a branch of optics, optical engineering, and nanotechnology.
Zalevsky sees Israel’s distinctive power in the way it turns theory into practice. “One of Israel’s greatest strengths is its ability to transform scientific excellence into real‑world impact,” he told Community Magazine.
“What makes our innovation ecosystem unique is the close partnership between universities, research institutions, entrepreneurs, industry, investors, and government, allowing new ideas to move from the laboratory to society with remarkable speed.”
Zalevsky believes the next phase will hinge on tightening those links.
Close Collaboration
“I believe the next few years will be defined by our ability to further shorten the path from scientific discovery to real‑world impact through even closer collaboration between academia, industry, entrepreneurs, investors and government – particularly in areas such as artificial intelligence, energy‑efficient computing and next‑generation semiconductor technologies,” he notes.
“Especially in challenging times, Israeli researchers remain relentlessly focused on solving meaningful problems, and that commitment to innovation gives me every confidence that Israel will continue to shape the next generation of global technologies.”
On the biotech side, Tel Aviv-based Mati Gill, CEO of AION Labs, and Dr. Yuval Cabily, Founding Board Member of AION Labs and Managing Partner at Israel Biotech Fund, described a similar pattern for Community.
Four Pillars of Israeli Biotech
Gill points to four pillars that, in his view, explain why Israel produces so much biotech and life‑science innovation despite its modest size.
First, Israel’s scientific base is unusually strong. Institutions like the Weizmann Institute, Technion, Tel Aviv University, and Hebrew University generate “world‑class and relevant” research for future pharma and biotech industries, and they turn out an “exceptional volume and quality of principal investigators and PhDs.”
Second, Israel’s leadership in technologies such as artificial intelligence, machine learning, and other computational disciplines gives biotech a deep digital backbone as the industry becomes increasingly data‑driven.
Third, Gill highlights the culture of entrepreneurship that connects these two worlds – life sciences on one side, math and computing on the other – and turns them into real companies.
Israel is one of the only places in the world that has genuine strength in both scientific disciplines and the ability to fuse them into products.
Fourth, Gill points to strong institutional and governmental backing, from Israel’s National Authority for Innovation to ministries that have formally prioritized biotech and tech as industries of strategic importance.
Political Climate and the Long Term
When asked how the current political climate affects global adoption, Cabily acknowledged that getting innovation accepted worldwide is always an uphill battle, and Israel faces its own distinctive hurdles.
Looking ten years ahead, he expects Israeli innovation to zero in on “deep technologies” with genuine differentiation – quantum computing, advanced AI, new energy infrastructure, and biotech – alongside continued leadership in defense technologies as global demand for security grows.
Innovation Beyond the Battlefield
With that frame in mind, the question becomes: What does Israeli innovation look like when it is no longer defined primarily by the battlefield?
It is easiest to see the answer first in cyberspace. For most people, Israeli innovation is invisible. Yet, every time a suspicious email lands in your spam folder instead of in your inbox, there is a good chance an Israeli engineer helped make that decision.
Outlook runs on Microsoft 365, on cloud patterns devised in Herzliya and Haifa. Gmail accounts are defended by machine‑learning models tuned in Tel Aviv. Even Proton Mail, the Swiss privacy‑first service, has relied on Israeli defenses. For years it depended on Radware, an Israeli cybersecurity and application‑delivery company, to scrub away massive waves of online attacks.
The basic problem is simple. Every major email service is under nonstop attack from hackers and spammers trying to steal passwords, plant viruses, or trick users into sending money.
Filters have to scan billions of messages, check for patterns that look dangerous, and decide whether to let them through, quarantine them, or block them altogether.
Israeli companies and R&D teams have become world leaders in building these “immune systems” for the internet – software that quietly sorts good signals from bad in fractions of a second.
Industry Giants Tied to Israel
Microsoft doesn’t just have an office in Israel. It treats Israel as a strategic development hub. The Microsoft Israel Development Center spans Herzliya, Tel Aviv, Haifa, and Nazareth, with thousands of employees working on cybersecurity, AI, big data, and cloud services.
Outlook and Exchange Online do not show an Israeli flag on the login page, but the secure cloud they run on – and the identity‑management and threat‑detection systems that protect them – are heavily shaped by this engineering footprint.
Google’s story is similar. Since 2005, it has built major R&D centers in Tel Aviv and Haifa, staffed by teams that design algorithms used to label spam, spot phishing attempts, and block malicious attachments.
Project Nimbus is a $1.2 billion cloud computing and AI contract awarded to Google and Amazon Web Services by the Israeli government in 2021. It provides the entire Israeli public sector (including civilian ministries and the defense establishment) with advanced cloud infrastructure, date storage, and machine learning capabilities. This deal with the Israeli government is driving new local data‑center builds and security tools. The hard lessons from meeting Israel’s regulatory and security demands feed back into how Google protects its cloud globally.
Even services that advertise themselves as sovereign alternatives to big tech, like Proton Mail, have found that when intense attacks hit, they need Israeli‑grade defenses.
Look to the Future
In the coming years, as work tools rely more heavily on artificial intelligence and as attackers themselves use AI to generate more convincing scams, Israeli cyber innovation is likely to move even deeper into the background.
Startups such as Torq, Cyera, Dream Security, and Cyberdomo are already using AI agents to automate the work of human analysts – spotting odd behavior across a company’s devices, checking where sensitive data is stored and triggering pre‑planned responses within seconds.
To the average user, the experience will remain simple: fewer dangerous emails get through, fewer accounts are hijacked, and more attacks are stopped before they reach the screen.
On the battlefield, the same mindset becomes visible. Israel’s more prominent innovations still sit squarely in the security realm.
Iron Dome and Iron Beam
Iron Dome, the missile defense system that intercepts rockets aimed at Israeli cities, has become a global symbol of high‑tech protection. Now, a new tool has joined it: Iron Beam, a ground‑based laser that can shoot down incoming threats using focused energy instead of explosives.
After more than three decades of development, Iron Beam was declared operational in late 2025 and moved into full‑rate production for the Israel Defense Forces. Integrated with Iron Dome’s management system, the laser neutralizes rockets, mortars, and drones within seconds at ranges of around six miles.
Each pulse costs only a few dollars, compared with roughly $50,000 for a single Tamir interceptor missile. That gap hints at a future where defending cities against swarms of cheap drones or rockets becomes financially sustainable.
In June 2026, Israel completed tests on an upgraded Iron Dome that fully integrated Iron Beam, allowing commanders to choose in real time whether to fire a missile or a laser, based on the type of threat, system status, and cost.
Officials hope to extend laser coverage to more powerful ballistic missiles as technology improves.
Hybrid Approach
More than any single hardware system, this hybrid defense approach captures Israel’s innovation mindset.
Instead of stacking ever more complex missiles, engineers fuse different methods – kinetic interceptors and directed energy – under one intelligent brain. The same thinking is now migrating into civilian contexts: mixing traditional tools with AI and automation, and shifting from manual reaction to machine‑speed prevention.
If defense tech shows how Israel protects itself today, medical innovation offers a glimpse of how it wants to protect people tomorrow.
A striking recent example comes from Rabin Medical Center in Petach Tikvah, where doctors have begun treating blood cancer patients with Israel’s first fully homegrown CAR‑T therapy for multiple myeloma.
For the first three patients, that has meant watching their own immune cells leave the body, be retrained in the lab, and return as a targeted army against the cancer.
CAR‑T therapy is, at heart, a way of retraining the body’s immune system. Doctors take some of a patient’s own T‑cells – white blood cells that normally help fight infections – and modify them so they can recognize and attack cancer cells that have learned to hide. Those upgraded cells are then returned to the patient, where they hunt down and destroy malignant cells that resist standard treatments.
Until now, many countries have relied on imported protocols and manufacturing to deliver such therapies, which can be expensive and slow. By developing and producing CAR‑T locally at the Samueli Integrative Cancer Pioneering Institute within the Davidoff Cancer Center, Israeli researchers hope to cut costs, shorten turnaround times and tailor treatments to local patient populations.
The first three patients received the therapy without unusual complications and were discharged as planned, with early results showing highly positive responses according to the oncologists.
Health-tech Push
This single case sits inside a broader health‑tech push. At conferences such as MIXiii‑Biomed, Israeli startups showcase tools that bring this mindset into clinics and homes.
One company, for instance, blends hospital imaging records with genetic data to suggest personalized treatment options, helping doctors to spot subtle issues earlier and to tailor care to each patient.
For non‑specialists, the pattern is straightforward. Israel is trying to do for medicine what it did for cybersecurity: build systems that watch continuously, learn from new data, and offer specific, timely interventions rather than generic ones.
Instead of waiting for a problem to become obvious, these tools raise early warning flags – a suspicious shadow in an image, an unusual heartbeat pattern, a drug response that does not follow expected paths.
Business Tools
Beyond healthcare, the same approach is reshaping everyday business tools. At Microsoft’s Ignite conference in November 2025, Israeli R&D groups were credited with leading several flagship AI security and “agentic” products – systems that can act on their own rather than simply answer questions.
One example is the Security Dashboard for AI, which gives companies a single view of all the AI elements they are using: chatbots, decision‑making tools, and automation scripts. Think of it as a control room where a security team can see which digital helpers are running in the background, what data they touch, and whether any of them pose risks.
Israeli engineers helped build the eyes and nerves of that control room – the parts that watch activity, spot anomalies, and channel alerts to human staff.
Outer Space
Perhaps the most dramatic vision of Israel’s future innovation lies off‑planet. In January 2026, Israel launched a national space research and development lab designed as an innovation hub for startups and deep‑space partnerships.
The lab offers shared infrastructure where companies can test new materials, sensors, and autonomous systems destined for orbital and lunar missions.
For small startups that could never afford specialized test facilities, access to simulation environments and flight opportunities with global launch partners dramatically lowers the barrier to entry.
One standout player is Helios, an Israeli startup developing an electrochemical reactor that can extract oxygen and metals from lunar soil.
The idea is simple. Instead of hauling fuel and life‑support oxygen from Earth, future missions could “live off the land,” producing these essentials directly on the Moon.
Oxygen could be used both for breathing and as a component of rocket fuel. Metals could support construction and maintenance. This approach could make longer‑term lunar stays far cheaper and more practical.
Success in Innovation
All of this innovation unfolds against a complex political backdrop. International debates over Israel’s policies, calls for boycotts, and concerns about surveillance and military technology create headwinds for global adoption.
Gill and Cabily do not downplay these realities, but they emphasize that success in innovation is always an uphill battle everywhere. Most startups fail for reasons unrelated to politics, said Gill. Think of technology that does not scale (meaning technology cannot handle a massive increase in users, data, or workload without breaking down, becoming prohibitively expensive, or requiring a full overhaul), markets that do not materialize, or simple timing.
In Israel’s case, political controversies add another layer of challenge, but they are viewed inside the ecosystem as obstacles to be managed rather than insurmountable walls.
The key, according to voices like Zalevsky and the AION Labs team, is long‑term discipline.
The Future
Israel’s innovation community has mapped out where it wants to be in ten years – in biotech, deep technologies, AI, energy, and defense – and is working systematically toward those goals.
Partnerships with global pharma, cloud giants, and space agencies create channels through which Israeli ideas can reach the world even when headlines are hostile.
Taken together, defense lasers, cancer therapies, enterprise agents, and lunar reactors show an ecosystem intent on shaping the infrastructure of global life, not just its battlefields.